ReviewHealth affairs scholar2026
The impact of cash and near-cash social policies on substance use outcomes: a scoping review.
Review in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Self-reported cannabis use following cash transfer: Estimating the short-term impacts of the Alaska Permanent Fund Dividend.The International journal on drug policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Background: The impact of government financial assistance and substance use is contested by 2 competing hypotheses: the "income effect" posits that cash transfers could facilitate substance consumption, while the "stress-relief hypothesis" posits that cash transfers alleviate poverty-related stress that contributes to substance use. Methods: We conducted a scoping review of 46 studies (2000-2025) evaluating US cash and near-cash safety net programs on substance use outcomes, following PRISMA-ScR guidance. Results: Evidence was most robust for tax credits, the Earned Income Tax Credit and Child Tax Credit, reducing tobacco use, particularly among lower-educated mothers. Evidence was suggestive but design-limited for Unemployment Insurance buffering overdose mortality in contexts of job loss, as most studies were ecological. Findings on alcohol and opioid outcomes were generally limited or null. Restrictions in near-cash supports, including drug-felony bans on the Supplemental Nutrition Assistance Program, were associated with higher rates of opioid misuse and substance use disorders. Disbursement design also mattered: lump-sum disability payments and synchronous COVID-era stimulus disbursements were linked to short-term spikes in overdose mortality ("check effect"), while stable, smaller benefits supported treatment retention. Conclusions: The US safety net plays a meaningful role in substance-related outcomes, with evidentiary strength varying considerably by program and substance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.